Back to results
US 2012/0252844 A1Published application
2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
AssigneeDeuteria Pharmaceuticals, Inc.
InventorSheila DeWitt
Life of this patent
Estimating the term…
Abstract
The present application describes 2-(2′,6′-dioxo-3′-deutero-piperidin-3′-yl)isoindoles, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
Claims24
A deuterium-enriched compound of formula I or a stereoisomer or pharmaceutically acceptable salt thereof:
- wherein:
- one of R8-R8a is —(CR9R10)nA and the other is selected from H and D;
- alternatively, R8a is —OR12a, and R8 is selected from H and D;
- A is N11R12;
- alternatively, when n=1, then A is selected from D, H, and NR11R12;
- one of X and Y is C═O and the other is selected from CH2, CHD, CD2, and C═O;
- Z is H or D, provided that the abundance of deuterium in Z is at least 30%;
- R1-R7 and R9-R10 are independently selected from H and D;
- R11 is selected from H, D, and CH3;
- R12 is selected from H, D, (C1-C8)alkyl, (C3-C7)cycloalkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C0-C4)alkyl-aryl, (C0-C4)alkyl-(C1-C6)heterocycloalkyl, (C0-C4)alkyl-(C2-C9)heteroaryl, C(O)R13, C(S)R13, C(O)OR14, (C1-C8)alkyl-N(R16)2, (C1-C8)alkyl-OR15, (C1-C8)alkyl-C(O)OR15, C(O)NHR13, C(S)NHR13, C(O)NR13R13′, C(S)NR13R13′, and (C1-C8)alkyl-O(CO)R15;
- provided that when n=0, R12 is other than H or D;
- R12a is selected from CH2—Ra—Rb—Rc, H, (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C0-C4)alkyl-(C3-C7)cycloalkyl, C(O)(C1-C8)alkyl, C(O)O(C1-C8)alkyl, C(O)NH(C1-C8)alkyl, C(O)N((C1-C8)alkyl)2, C(O)(C3-C7)cycloalkyl, (C0-C4)alkyl-aryl, (C0-C4)alkyl-(C1-C6)heterocycloalkyl, (C0-C4)alkyl-(C2-C9)heteroaryl, C(O)aryl, C(O)(C1-C6)heterocycloalkyl, and C(O)(C2-C9)heteroaryl, and R12a is optionally substituted with 1-3 groups selected from (C1-C6)alkyl, (C1-C6)haloalkyl, (C1-C6)alkoxy, (C1-C6)haloalkoxy, ═O, NR202, CO2R20, C(O)NH(C1-C8)alkyl, C(O)N((C1-C8)alkyl)2, NO2, —CN, OH, halogen, and S(O)2(C1-C8)alkyl;
- Ra is a bond, alternatively, Ra is selected from aryl, (C1-C6)heterocycloalkyl, and (C2-C9)heteroaryl, wherein Ra is optionally substituted with 1-3 halogen;
- Rb is selected from (CH2)m, O(CH2)m, and (CH2)mO;
- m is selected from 0-3;
- Rc is selected from aryl, (C1-C6)heterocycloalkyl, and (C2-C9)heteroaryl, and Rc is substituted 0-2 groups selected from (C1-C6)alkyl, (C1-C6)haloalkyl, (C1-C6)alkoxy, (C1-C6)haloalkoxy, ═O, NR202, CO2R20, —CN, OH, halogen, S(O)2(C1-C8)alkyl, aryl substituted with 0-2 Rd, and (C2-C9)heteroaryl substituted with 0-2 Rd;
- Rd is selected from (C1-C6)alkyl, (C1-C6)haloalkyl, (C1-C6)alkoxy, (C1-C6)haloalkoxy, halogen, CONR202, CO2(C1-C6)alkyl, and CO2(C1-C6)haloalkyl;
- R13 is selected from H, (C1-C8)alkyl, (C3-C7)cycloalkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C0-C4)alkyl-aryl, (C0-C4)alkyl-(C1-C6)heterocycloalkyl, (C0-C4)alkyl-(C2-C9)heteroaryl, (C0-C8)alkyl-N(R16)2, (C1-C8)alkyl-OR15, (C1-C8)alkyl-C(O)OR15, (C1-C8)alkyl-O(CO)R15, and C(O)OR15;
- R13′ is selected from (C1-C8)alkyl, (C3-C7)cycloalkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C0-C4)alkyl-aryl, (C0-C4)alkyl-(C1-C6)heterocycloalkyl, (C0-C4)alkyl-(C2-C9)heteroaryl, (C0-C8)alkyl-N(R16)2, (C1-C8)alkyl-OR15, (C1-C8)alkyl-C(O)OR15, (C1-C8)alkyl-O(CO)R15, and C(O)OR15;
- R14 is selected from (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C1-C4)alkyl-OR15, (C0-C4)alkyl-aryl, (C0-C4)alkyl-(C1-C6)heterocycloalkyl, and (C0-C4)alkyl-(C2-C9)heteroaryl;
- R15 is selected from H, (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C0-C4)alkyl-aryl, and (C2-C9)heteroaryl;
- R16, at each occurrence, is independently selected from H, D, (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C0-C4)alkyl-aryl, (C2-C9)heteroaryl, and (C0-C8)alkyl-C(O)OR15;
- alternatively, N(R16)2 forms a heterocycloalkyl group;
- n, at each occurrence, is selected from 0, 1, 2, and 3;
- the cycloalkyl, heterocycloalkyl, aryl, and heteroaryl groups are optionally substituted with 1-3 R17;
- R17, at each occurrence, is independently selected from H, D, halogen, NO2, —CN, (C1-C8)alkyl, (C1-C6)haloalkyl, (C1-C6)alkoxy, (C1-C6)haloalkoxy, (C1-C6)alkyenedioxy, —NHC(O)(C1-C6)alkyl, CH2OCH3, CH2CH2OCH3, S—(C1-C8)alkyl, SO2(C1-C8)alkyl, S—(C1-C8)haloalkyl, SO2(C1-C8)haloalkyl, (C0-C4)alkyl-R17a, (C0-C4)alkyl-R18, —O—(C0-C4)alkyl-R18, —(CH2—R19)p—R18, OC(O)(CH2)pNH2, and OC(O)(CH2)p(C1-C6)heterocycloalkyl;
- p, at each occurrence, is selected from 0, 1, and 2;
- R17a, at each occurrence, is independently selected from OH, NH2, and CO2R20;
- R18, at each occurrence, is independently selected from aryl, (C1-C6)heterocycloalkyl, and (C2-C9)heteroaryl, wherein each aryl, heterocycloakyl, and heteroaryl is optionally substituted with 1-3 (C1-C8)alkyl;
- R19, at each occurrence, is independently selected from CH2, NH, and O;
- R20 is selected from H and (C1-C8)alkyl;
- wherein a hydrogen atom present in any of the substituents is optionally replaced by deuterium.
29 more elements
Dependencies are inferred from the claim text.